COVID-19
FDA advisors say new COVID-19 vaccines should be monovalent, targeting XBB
An FDA advisory committee voted Thursday to recommend changing the composition of the country’s COVID-19 vaccines to be monovalent XBB-lineage vaccines, removing the wild strain of SARS-CoV-2 from the shots.
Postural orthostatic tachycardia syndrome a common complication of COVID-19
PHILADELPHIA — Postural orthostatic tachycardia syndrome is a common cardiac complication in COVID-19 survivors and research is ongoing as to optimal treatments, a speaker said during the Heart in Diabetes CME Conference.
VIDEO: In COVID-19, MI risk elevated with at least one cardiometabolic risk factor
PHILADELPHIA — In this Healio video exclusive, Healio | Cardiology Today Editorial Board Member Susan Cheng, MD, MPH, MMSc, discusses the excess risk for heart attack in patients with COVID-19.
Metformin may reduce risk for long COVID among adults with obesity
Adults with overweight or obesity who received metformin shortly after a COVID-19 diagnosis had a lower risk for developing long COVID than those receiving placebo, according to study data.
Reusing disposable masks has no major impact on skin, upper respiratory microbiome
Reusing single-use surgical masks for up to a week had no major impact on skin or upper respiratory tract microbiomes, according to data published in The Journal of Infectious Diseases.
Low vitamin D levels observed among adults with long COVID 6 months post-infection
Adults diagnosed with COVID-19 who had long COVID at a 6-month follow-up had lower vitamin D levels than COVID-19 survivors without long COVID, according to data published in The Journal of Clinical Endocrinology & Metabolism.
Understanding how health care providers can prompt vaccine uptake
WASHINGTON — There are different ways to promote vaccination, and provider-patient communication is a major component to addressing vaccine hesitancy, according to a presentation at the American Thoracic Society International Conference.
Adults hospitalized with COVID-19 have lower thyroglobulin levels with glucocorticoid use
Thyroglobulin levels differed by glucocorticoid use, but not by thyroid function, among a cohort of adults hospitalized for COVID-19, according to findings published in Frontiers in Endocrinology.
Paxlovid, Lagevrio reduce mortality risk in patients with COVID-19
As an outpatient treatment for COVID-19, the antivirals Paxlovid and Lagevrio were both associated with reduced mortality rates, but only Paxlovid was associated with a reduction in hospitalization, data show.
Transplant medicine contends with organ shortage and pandemic-related disruptions
Transplant medicine and the field of transplant infectious diseases have faced numerous disruptions and challenges during the COVID-19 pandemic, according to experts.